Infectious cDNA clone of the modified live virus vaccine strain of Equine arteritis virus
AssigneeUniversity of Kentucky Research Foundation
InventorsUdeni B. R. Balasuriya, Peter J. Timoney, Jianqiang Zhang
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Kentucky Research Foundation
InventorsUdeni B. R. Balasuriya, Peter J. Timoney, Jianqiang Zhang
Estimating the term…
An isolated polynucleotide molecule includes a DNA sequence encoding an infectious RNA molecule encoding a modified live viral strain of an Equine arteritis virus, wherein the DNA sequence is SEQ ID NO:1 or a degenerate variant thereof. Also provided are transformed or transfected host cells including that sequence, vectors including the sequence, and isolated infectious RNA molecules encoded by the sequence. Further, a modified DNA sequence encoding an infectious RNA molecule encoding a modified live viral strain of an Equine arteritis virus is provided wherein the DNA sequence is SEQ ID NO:2 or a degenerate variant thereof, including a silent point mutation allowing distinguishing the modified sequence from the parent and other strains of Equine arteritis virus.
An isolated polynucleotide molecule comprising a DNA sequence encoding an infectious RNA molecule encoding a modified live viral strain of an Equine arteritis virus, wherein said DNA sequence is SEQ ID NO:1.
An isolated polynucleotide molecule comprising a DNA sequence encoding an infectious RNA molecule encoding a modified live viral strain of an Equine arteritis virus, wherein the DNA sequence is SEQ ID NO:2.
Dependencies are inferred from the claim text.